Company Analysis Spectral Medical Inc.
1. Summary
Advantages
- The stock's return over the last year (81.29%) is higher than the sector average (-28.97%).
- The company's current efficiency (ROE=69.86%) is higher than the sector average (ROE=14.51%)
Disadvantages
- Price (0.93 $) is higher than fair price (0.7689 $)
- Dividends (0%) are below the sector average (1.7%).
- Current debt level 280.55% has increased over 5 years from 5.9%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Spectral Medical Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -38.9% | 0.5% |
| 90 days | -17% | -36.3% | 3.5% |
| 1 year | 81.3% | -29% | 16.2% |
EDTXF vs Sector: Spectral Medical Inc. has outperformed the "Healthcare" sector by 110.26% over the past year.
EDTXF vs Market: Spectral Medical Inc. has outperformed the market by 65.11% over the past year.
Stable price: EDTXF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EDTXF with weekly volatility of 1.56% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (0.93 $) is higher than the fair price (0.7689 $).
Price is higher than fair: The current price (0.93 $) is 17.3% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-14.46) is lower than that of the sector as a whole (45.46).
P/E vs Market: The company's P/E (-14.46) is lower than that of the market as a whole (45.85).
5.3. P/BV
P/BV vs Sector: The company's P/BV (-5.07) is lower than that of the sector as a whole (5.31).
P/BV vs Market: The company's P/BV (-5.07) is lower than that of the market as a whole (4.38).
5.5. P/S
P/S vs Sector: The company's P/S indicator (61.14) is higher than that of the sector as a whole (4.3).
P/S vs Market: The company's P/S indicator (61.14) is higher than that of the market as a whole (12.4).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-12.68) is lower than that of the sector as a whole (17.43).
EV/Ebitda vs Market: The company's EV/Ebitda (-12.68) is lower than that of the market as a whole (24.93).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 15.06% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (15.06%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-61.97%).
6.4. ROE
ROE vs Sector: The company's ROE (69.86%) is higher than that of the sector as a whole (14.51%).
ROE vs Market: The company's ROE (69.86%) is higher than that of the market as a whole (51.21%).
6.6. ROA
ROA vs Sector: The company's ROA (-292.51%) is lower than that of the sector as a whole (7.45%).
ROA vs Market: The company's ROA (-292.51%) is lower than that of the market as a whole (36.06%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.14%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.78%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.7%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.5.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
